Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial

Neurology

Volumn 54, Issue 1, 2000, Pages 77-82

  Roos, Y ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antifibrinolytic treatment; Randomized trial; Subarachnoid hemorrhage

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CALCIUM ANTAGONIST; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLASGOW COMA SCALE; HUMAN; HYDROCEPHALUS; HYPERVOLEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VOMITING;

EID: 0033962206     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.1.77     Document Type: Article

References (25)

1. Whitfield PC, Moss H, Ohare D, Smielewski P, Pickard JD, Kirkpatrick PJ. An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding. J Neurol Neurosurg Psychiatry 1996;60:301-306.
2. Roos YBWEM, Beenen LFM, Groen RJM, Albrecht KW, Vermeulen M. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 1997;63:490-493.
3. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994;25:1342-1347
4. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993;43:712-718.
5. Leipzig TJ, Redelman K, Horner TG. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg 1997;86:220-225.
6. Lindsay KW. Antifibrinolytic agents in subarachnoid haemorrhage. J Neurol 1987;234:1-8.
7. Roos Y, Rinkel GJE, Algra A, van Gijn J, Vermeulen M. Antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1998;65:942-943.
8. Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996;84:405-414.
9. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50: 876-883.
10. Beck DW, Adams HP, Flamm ES, Godersky JC, Loftus CM. Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage. Stroke 1988; 19:63-67.
11. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:2315-2328.
12. Dippel DWJ. Management of subarachnoid haemorrhage in Decision analysis in the clinical neurosciences. Thesis Publishers, Amsterdam 1994:145-161.
13. Hijdra A, Brouwers PJAM, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms of the subarachnoid hemorrhage. Stroke 1990;21:1156-1161.
14. Vermeulen M, van Gijn J. The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:365-372.
15. Kinkel GJ, Wijdicks EF, Hasan D, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991;338:964-968.
16. Rinkel GJ, Wijdicks EF, Vermeulen M, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol 1991;12:829-834.
17. Vermeulen M, Hasan D, Blijenberg BG, Hijdra A, van Gijn J. Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry 1989;52:826-828.
18. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81-84.
19. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988;51:1457.
20. Brouwers PJ, Dippel DW, Vermeulen M, Lindsay KW, Hasan D, van Gijn J. Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke 1993;24:809-814.
21. Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990;27:106-108.
22. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
23. Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984; 311:432-437.
24. van Gijn J, Bromberg JEC, Lindsay KW, Hasan D, Vermeulen M. Definition of initial grading, specific events, and overall outcome in patients with aneurysmal subarachnoid hemorrhage: a survey. Stroke 1994;25:1623-1627.
25. Smith B. Cerebral pathology in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1963;26:535-539.